PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software Live Events PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software – Scarman, Coventry, UKCertaraOctober 14, 2025
MBMA vs. Meta-Analysis: Quick Comparison Guide Guide MBMA vs. Meta-Analysis: Quick Comparison Guide Discover how Model-Based Meta-Analysis (MBMA) outperforms traditional meta-analysis in drug development by predicting outcomes, informing…CertaraOctober 8, 2025
Certara University: Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings On-Demand Webinar Certara University: Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings Watch Certara’s webinar with Kristin Follman to discover how TFL Studio streamlines the process to…CertaraSeptember 22, 2025
Top 10 Things to Know About ADNCA for Non-Compartmental Analysis Guide Top 10 Things to Know About ADNCA for Non-Compartmental Analysis Learn how to transition from non-standard ADPC datasets to the CDISC ADNCA ADaM standard. Improve…CertaraSeptember 11, 2025
What is a Loading Dose? BlogKnowledge Base What is a Loading Dose? Learn what a loading dose is, why it's vital for reaching therapeutic drug levels swiftly,…CertaraSeptember 10, 2025
The Pharmacometrics Africa Conference 2025 (PMXAC-2025) Conference The Pharmacometrics Africa Conference 2025 (PMXAC-2025) CertaraSeptember 4, 2025
Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH) On-Demand Webinar Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH) Learn to design drug development programs for First-in-Human (FIH) success with biomarkers, PK/PD modeling, and…CertaraAugust 29, 2025
Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Publication Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…CertaraAugust 13, 2025